Sigba, Cjay .
HRN: 22-77-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2023
AMPICILLIN 250MG (VIAL)
11/10/2023
11/17/2023
IV
250mg
Q6hours
PCAP-C; R/o PTB
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes